How are Triglyceride senken and menopause related?

Menopause involves a decline in estrogen, which alters lipid metabolism. Estrogen enhances fatty acid uptake and utilization; its drop can increase hepatic triglyceride production. Additionally, visceral fat accumulation rises, promoting insulin resistance and further elevating triglycerides. Many women experience a rise in fasting triglycerides during perimenopause and postmenopause. Lowering them is achievable through lifestyle: a Mediterranean diet rich in omega-3s (fish, flaxseed), regular aerobic and resistance exercise, weight management, and reducing simple carbohydrates. Hormone replacement therapy may lower triglycerides in some women but requires individual risk-benefit assessment. Genetic testing for lipid-related variants (e.g., APOE, LPL) offers only weak, population-level associations and does not replace a standard lipid panel. The evidence is based on observational studies and physiological mechanisms, not on randomized trials with genetic stratification. Thus, the predictive power for an individual is limited. Clinical monitoring and lifestyle remain the cornerstone.